Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Price:
6.365
USD
-5.98%
Market Closed
Market Cap:
$14.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
US |
|
Indonesian Paradise Property Tbk PT
IDX:INPP
|
ID |
|
CubicFarm Systems Corp
TSX:CUB
|
CA |
|
N
|
Nimy Resources Ltd
ASX:NIM
|
AU |
|
Adese Gayrimenkul Yatirim AS
IST:ADESE.E
|
TR |
|
E
|
Evotec SE
OTC:EVOTF
|
DE |
|
S
|
Swiss Properties Invest A/S
CSE:SWISS
|
DK |
|
WPG Holdings Ltd
TWSE:3702
|
TW |
|
BNP Paribas SA
PAR:BNP
|
FR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CYCC's stock price target?
Not Available
CYCC doesn't have any price targets made by Wall Street professionals.
What is Cyclacel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
1 141%
1 141%
The
compound annual growth rate
of Cyclacel Pharmaceuticals Inc's revenue for the next 3 years is
1 141%.
